Health Research Institute: Life sciences

All publications
Providers
 Payers
Employers
 Pharmaceuticals
Life sciences
Sort by title   Sort by date

The Health Research Institute of PricewaterhouseCoopers provides new intelligence, perspective and analysis on trends affecting all health-related industries, including healthcare providers, pharmaceuticals, health and life sciences and payers.

HealthCast 2010: Smaller world, bigger expectations
Consumerism, E-business and genomics will be the disruptive drivers of this decade, according to this 1999 global research report that included a mix of policy makers, health system executives, employers, physicians, insurers and medical supply vendors from the US, Europe, Canada and Australia. This report looks at those disruptive drivers and the way they'll affect providing and paying for healthcare in the future.
HealthCast 2020: Creating a sustainable future
In this groundbreaking report, HealthCast 2020, the Health Research Institute looks at solutions and responses from around the world to the globalization and industrywide convergence of healthcare. What insights, best practices and policy lessons can be learned from experiences in various countries to create a globally sustainable health system? Who, or what, is driving the solutions?
HealthCast tactics: A blueprint for the future
Building on HealthCast 2010, this 2002 report recommends tactics that successful health systems and payers should consider employing over the next three to five years. Among the tactics are pay-for-performance, predictive modeling, and renewing capital plants, all of which are strongly affecting the industry today. The report draws on a survey of more than 650 top executives of hospital systems, payers, governments, medical supply vendors, physician groups and employers.
Personalized medicine: The emerging pharmacogenomics revolution
The report from PricewaterhouseCoopers' Global Technology Centre and Health Research Institute provides insights into the challenges and opportunities afforded by pharmacogenomics.
Recapturing the vision: Restoring trust in the pharmaceutical industry by translating expectations into actions
Significant differences between the public's perception of pharmaceutical companies and their own self perception has caused the pharmaceutical industry to lose the trust of its key stakeholders. This report examines those gaps in the areas of marketing and research and development. It also provides recommendations on ways the industry can recapture the reputation it once commanded.
The quality conundrum: Practical approaches for enhancing patient care
This 200-page book is a compilation of thought-provoking essays by PwC and industry experts on quality in provider, payer, pharmaceutical and employer organizations in the US and around the world. It explores the barriers that have made healthcare quality improvements difficult to achieve, and outlines a clear path to progress. Take a journey through the healthcare system from the patient's perspective.
Top eight health industry issues in 2008
Health organizations face a pivotal year in 2008 as they anticipate the wildcard outcome of the presidential election. Meanwhile, they must prepare for impending changes — pharmaceutical and life sciences companies are adapting to a new safety agenda from the FDA including the agency's expanded authority over post-market drug safety. See more